The following license files are associated with this item:
- QMRO Home
- William Harvey Research Institute
- Centre for Biochemical Pharmacology
- A randomised, double-blind, placebo-controlled, multicentre clinical trial of AZD1656 in diabetic patients hospitalised with COVID-19: The ARCADIA Trial- implications for therapeutic immune modulation
Browse
Administrators only